2.Atypical extraventricular neurocytoma: report of a case.
Yan LI ; Jing FU ; Yanke GUO ; Zhichao WANG
Chinese Journal of Pathology 2014;43(11):774-775
5.Intracranial giant glioma in a neonate.
De-yuan MA ; Xiao-mei CHEN ; Xin-dong ZHANG
Chinese Journal of Pediatrics 2007;45(3):235-236
Brain Neoplasms
;
pathology
;
Glioma
;
pathology
;
Humans
;
Infant, Newborn
;
Male
6.Tumor mass of cranial frontal region.
Chinese Journal of Pathology 2008;37(9):641-642
Adult
;
Brain Neoplasms
;
pathology
;
Female
;
Frontal Lobe
;
pathology
;
Humans
;
Skull
7.Seizure-susceptible brain regions in patients with low-grade gliomas.
Journal of Central South University(Medical Sciences) 2018;43(4):342-344
Patients afflicted with low-grade glioma frequently suffer from seizures. The mechanisms for seizure initiation in these patients remain poorly understood. Tumor location is correlated with seizure initiation. However, these correlative studies rely on dichotomized data analysis which is based on arbitrary lobe assignments. As a result, the lesion-symptom correlation may be incorrectly interpreted. Categorizing patients according to tumor involvement in a single brain lobe might cause the neglect of important information, such as lesion location and lesion volume. Tumors that invaded more than one brain lobe may could be counted repeatedly. The anatomic correlation of the tumor-induced seizures is therefore difficult to be identified. Investigations based on voxel-wise quantitative lesion analysis could avoid the above statistical bias. According to the voxel-wise analysis, the increased seizure risks were identified for patients with low-grade gliomas that involved the left premotor area.
Brain
;
pathology
;
Brain Neoplasms
;
complications
;
pathology
;
Glioma
;
complications
;
pathology
;
Humans
;
Seizures
;
etiology
10.Significance of Dynamic MRI in Brain Tumors.
Dong Woo KIM ; Soon Ki SUNG ; Young Jin SONG ; Soon Seop CHOI ; Dae Cheol KIM ; Young Min CHOI ; Won Ju HUH ; Ki Uk KIM
Journal of Korean Neurosurgical Society 2007;42(1):27-34
OBJECTIVE: On the magnetic resonance image (MRI) of the infiltrating brain tumor, enhancement is usually higher in malignant tumor than in benign tumor, and tumor cells can invade into the peritumoral area without definite enhancement. In various pathological conditions, the blood brain barrier (BBB) becomes changed to pathological condition, allowing various materials extravasating into the interstitial space, and degree of enhancement is depend on the pathology. Authors performed dynamic MRI on enhancing and surrounding edematous area in order to evaluate the degrees of opening of BBB, to differentiate tumor from non-tumorous condition, and to determine its relationship with the recurrence of the tumor. METHODS: Dynamic MRI was performed in 25 patients. Dynamic scans were done every 15 seconds after administration of Gd-DTPA on the enhancing and surrounding area for maximum 300 seconds, and the patterns of enhancement were analysed. The enhancement curve with initial steep increase followed by slow decrease was defined as "N pattern", those with initial steep increase followed by additional slow increase as "T pattern", and those with initial steep increase followed by plateau as "E pattern". Histopathological findings were compared with the dynamic scan. RESULTS: The graphs taken from enhancing area showed "T pattern" regardless of pathology. In the surrounding area, "T pattern" was noticed in the malignant tumors, but "E pattern" or "N pattern" was noted in low-grade or benign tumors and non-tumorous condition. "T pattern" in the surrounding area was related to the malignancy with tumor cell infiltration and recurrence. CONCLUSION: The results suggest that the malignant tumor infiltration changes the condition of BBB enough to extravasate the Gd-DTPA. Enhancement pattern in the surrounding edematous area may be a useful information to differentiate the malignant glioma with the low-grade and benign tumors or other non-tumorous conditions.
Blood-Brain Barrier
;
Brain Neoplasms*
;
Brain*
;
Gadolinium DTPA
;
Glioblastoma
;
Glioma
;
Humans
;
Magnetic Resonance Imaging*
;
Pathology
;
Recurrence